BeyondSpring Competitors and Similar CompaniesClear all
BeyondSpring's competitors and similar companies include Omeros, Athersys, Otonomy and Leap Therapeutics.
 BeyondSpring BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies. |  Omeros Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers. |  Athersys Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications. |  Otonomy Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear. |  Leap Therapeutics Leap Therapeutics (formerly known as HealthCare Pharmaceuticals) is a biopharmaceutical company developing targeted and immuno-oncology therapeutics. | |
Founding Date | Founding Date 2010 | Founding Date 1994 | Founding Date 1995 | Founding Date 2008 | Founding Date 2011 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Florham Park, US HQ | Locations Seattle, US HQ | Locations Cleveland, US HQ Canton, US | Locations San Diego, US HQ | Locations Cambridge, US HQ |
Employees | Employees 6712% decrease | Employees 1968% decrease | Employees 8311% increase | Employees 49 | Employees 5423% increase |
Valuation ($) | Valuation ($) 89.4 m | Valuation ($) 248.6 m | Valuation ($) 6.3 m | Valuation ($) 5.3 m | Valuation ($) 176.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $1.4m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $5.3m (FY, 2022) | Revenue (est.) $125k (FY, 2021) | Revenue (est.) N/A |
Net income | Net income ($36.3m) (FY, 2022) | Net income ($117.8m) (FY, 2023) | Net income ($72.5m) (FY, 2022) | Net income ($51.2m) (FY, 2021) | Net income ($81.4m) (FY, 2023) |
Operating ⚠ | |||||
Patents (US) | Patents (US) 20 (Mar, 2020) | Patents (US) 80 (FY, 2021) | Patents (US) 21 (FY, 2016) | Patents (US) N/A | Patents (US) N/A |
Patents Issued | Patents Issued N/A | Patents Issued N/A | Patents Issued 200 (FY, 2016) | Patents Issued 88 (FY, 2016) | Patents Issued N/A |
Phase I Trials Products | Phase I Trials Products 2 (FY, 2019) | Phase I Trials Products 3 (FY, 2021) | Phase I Trials Products N/A | Phase I Trials Products 1 (FY, 2016) | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products 1 (FY, 2017) | Phase II Trials Products 2 (FY, 2021) | Phase II Trials Products N/A | Phase II Trials Products 2 (FY, 2016) | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products 3 (FY, 2019) | Phase III Trials Products 2 (FY, 2021) | Phase III Trials Products N/A | Phase III Trials Products 2 (FY, 2016) | Phase III Trials Products N/A |
Pre-Clinical Phase Products | Pre-Clinical Phase Products 5 (FY, 2019) | Pre-Clinical Phase Products N/A | Pre-Clinical Phase Products N/A | Pre-Clinical Phase Products 1 (FY, 2016) | Pre-Clinical Phase Products N/A |
Funding | |||||
Total funding raised | Total funding raised $ 36.1m | Total funding raised $ 354.8m | Total funding raised $ 9m | Total funding raised $ 153.4m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Omeros
HQ
Seattle, US
Employees
196↓ 8% decrease
Omeros Corporation is a biopharmaceutical company developing products focused on inflammation and central nervous system disorders as well as immune-related diseases, including cancers.
View companyAthersys
HQ
Cleveland, US
Employees
83↑ 11% increase
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
View companyOtonomy
HQ
San Diego, US
Employees
49
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
View companyLeap Therapeutics
HQ
Cambridge, US
Employees
54↑ 23% increase
Leap Therapeutics (formerly known as HealthCare Pharmaceuticals) is a biopharmaceutical company developing targeted and immuno-oncology therapeutics.
View company